Publications
Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
EAACI/GA²LEN/EDF guideline: management of urticaria
| Filename | 47. Zuberbier et al.,Guideline Urticaria Management, Allergy 2006.pdf |
| Version | o.047 |
| Date added | May 25, 2020 |
| Downloaded | 0 times |
| Category | Original Work |
| Authors | Zuberbier, T., Bindslev-Jensen, C., Canonica, W., Grattan, C. E. H., Greaves, M. W., Henz, B. M., Kapp, A., Kozel, M. M. A., Maurer, M. Merk, H. F., Schäfer, T., Simon, D., Vena, G. A., and Wedi, B. |
| Citation | Zuberbier, T., Bindslev-Jensen, C., Canonica, W., Grattan, C. E. H., Greaves, M. W., Henz, B. M., Kapp, A., Kozel, M. M. A., Maurer, M. Merk, H. F., Schäfer, T., Simon, D., Vena, G. A., and Wedi, B.: EAACI/GA²LEN/EDF guideline: management of urticaria. Allergy 2006: 61; 321-331. IF: 5.33 |
| Corresponding authors | Zuberbier, T. |
| DocNum | O.47 |
| DocType | |
| Edition; Page | 61; 321-331 |
| IF | 5.33 |
| Publisher | Allergy |
| ReleaseDate | 2006 |
This guideline is the result of a consensus reached during a panel discussion at the second International Consensus Meeting on Urticara, Urticaria 2004, a joint initiative of the EAACI Dermatology Section and GA2
LEN. Urticaria has a profound impact on the quality of life, and effective treatment is therefore required. The recommended first line treatment are nonsedating H1 antihistamines. They have proven to be effective in double-blind controlled studies, but dosages increased up to fourfold over the recommended doses may be necessary. However, for different urticaria subtypes and in view of individual variation in
the course of the disease and response to treatment, additional or alternative therapies may be required. Immunosuppressive drugs like cyclosporin A and corticosteroids are not recommended for long-term treatment due to unavoidable severe adverse effects. This guideline was, in addition, accepted by the European Dermatology Forum (EDF) and formally approved by the European Union of Medical Specialists (UEMS).
(Last update: 12.2023)
| Number of original publications in peer-reviewed journals: | 580 |
| Number of reviews in peer-reviewed journals: | 210 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
| Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
| Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
| Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.